Tackling the Pandemic While the COVID-19 crisis has disrupted each of the mission areas of research, patient care, education and innovation at the CU Anschutz Medical Campus, we met the challenge with a swift response. In early March, university leadership moved to remote teaching, learning and work and jumpstarted important research in May. At UCHealth University of Colorado Hospital (UCH), healthcare providers and other frontline staff have continued their selfless work in caring for patients, and ensuring the health and safety of our community. The true heroes during this pandemic have not only been the patients who have braved this time, but also the healthcare providers, such as doctors, nurses, other team members and countless students. They are the dedicated individuals who are on the front lines, rallying to protect the health and well-being of patients and the wider community. We count you, our philanthropic community, among these heroes, raising more than $3 million to support coronavirus relief efforts. Funds have helped accelerate the pace of research for the prevention and treatment of COVID-19, as well as provided valuable resources to meet the needs of our medical staff at UCH. Your support has made an incredible impact in the fight against COVID-19.
The COVID-19 pandemic has been the most significant challenge our generation of healthcare providers has ever faced. Our philanthropic community has given us the flexibility to allocate resources to the greatest needs of our most vulnerable patients, families and caregivers during this unprecedented time. Christopher Gessner President & CEO, UCHealth University of Colorado Hospital
In the midst of the crisis, we have come together to lead and support efforts to battle the pandemic. We have achieved a great deal with your help: • We boosted access to telehealth to safely deliver care to more patients, ramping up online visits from a couple hundred per week to nearly 3,000 per day. • Multiple studies are underway on campus, including the first large-scale clinical trial of a coronavirus vaccine in the U.S. by Moderna. We plan to enroll patients in the 30,000-person experimental trial. We are also the sole regional site of a clinical trial of the antiviral drug Remdesivir. • Students contributed more than 12,000 volunteer service hours monitoring discharged patients, distributing food to providers and organizing personal protective equipment drives. • Our COVID-19 biobank has collected more than 15,000 biological samples from UCH and Children’s Hospital Colorado to inform ongoing research.
87,000 COVID-19 and antibody tests completed ‑3‑
